GlassScriptPhysician profile
Phu Sy Le
NPI 1073046371
$1,337.86
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $25.05 · 2022: $966 · 2023: $346.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $346.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $346.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $238.37 | 2022-2023 | |
| Sk Life Science, INC. | $226.52 | 2022-2023 | |
| Neurocrine Biosciences, INC. | $170.75 | 2022-2023 | Ongentys, Ingrezza |
| Genzyme Corporation | $100.92 | 2021-2022 | |
| Allergan, INC. | $90.15 | 2022 | |
| Biogen, INC. | $72.35 | 2022-2023 | Vumerity |
| Amgen INC. | $71.90 | 2022 | |
| Amneal Pharmaceuticals LLC | $70.41 | 2022-2023 | Rytary |
| Biohaven Pharmaceutical Holding Company LTD. | $43.82 | 2022 | |
| Medtronic, INC. | $32.86 | 2022-2023 | Linq II |
| Celgene Corporation | $29.34 | 2022 | |
| Impel Pharmaceuticals INC. | $26.39 | 2022-2023 | Trudhesa |
| Bayer Healthcare Pharmaceuticals INC. | $19.88 | 2023 | |
| Alexion Pharmaceuticals, INC. | $19.84 | 2023 | Ultomiris |
| Jazz Pharmaceuticals INC. | $18.79 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $17.55 | 2022 | |
| Axsome Therapeutics, INC. | $16.24 | 2023 | Sunosi |
| Neurelis, INC. | $15.63 | 2022 | |
| Emd Serono, INC. | $15.54 | 2022 | |
| Novartis Pharmaceuticals Corporation | $13.88 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $13.65 | 2023 | Austedo |
| Astrazeneca Pharmaceuticals LP | $13.08 | 2023 | Andexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phu Le listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.